Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 6 January 2021

Croatian is available via eTranslation, the European Commission's machine translation service.

Translate to Croatian | Important information about machine translation

Date

srijeda, 6 siječnja 2021, Cijeli dan

Lokacija

Online
European Medicines Agency, Amsterdam, the Netherlands

This extraordinary meeting is organised in the context of the evaluation of the COVID-19 vaccine mRNA-1273 developed by Moderna.

The aim of the meeting is to assess additional information received from the company upon request of the Agency and to conclude the evaluation, if possible.

The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

Share this page